29 April 2023
Clifford Chance advises Rivean Capital’s portfolio company To-Increase on its acquisition of AX for Pharma
Advising firms
Deal team
15 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Pieter Leefers Lead | Clifford Chance | Not stated | Not stated | Amsterdam |
| Robin Traas | Clifford Chance | Not stated | Corporate | Amsterdam |
| Ruben van Diepen | Clifford Chance | Not stated | Corporate | Amsterdam |
| Michiel Sunderman | Clifford Chance | Not stated | Tax | Amsterdam |
| Alec Sanderson | Clifford Chance | Not stated | Tax | Amsterdam |
| Cile Arnoldy | Clifford Chance | Not stated | Tax | Amsterdam |
| Leen Kranenburg | Clifford Chance | Not stated | Notary | Amsterdam |
| Milena Raffaldi | Clifford Chance | Not stated | Corporate | Milan |
| Francesco Romagnoli | Clifford Chance | Not stated | Corporate | Milan |
| Antoaneta Shikerova | Clifford Chance | Not stated | Corporate | Milan |
| Luciano Di Via | Clifford Chance | Not stated | Antitrust | Milan |
| Antonio Mirabile | Clifford Chance | Not stated | Antitrust | Milan |
| Luca Borin | Clifford Chance | Not stated | Antitrust | Milan |
| Marina Mobiglia | Clifford Chance | Not stated | Employment | Milan |
| Andrea Sgrilli | Clifford Chance | Not stated | Tax | Milan |
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- To-IncreaseBuy-side
- Counterparties
- AX for Pharma (Sell-side)